A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials.

Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found.

An already approved breast cancer drug could bring hope to thousands of UK women who have an aggressive form of breast cancer, new research has found.